| Year |
Citation |
Score |
| 2021 |
Van AN, Kunkel MT, Baffi TR, Lordén G, Antal CE, Banerjee S, Newton AC. Protein kinase C fusion proteins are paradoxically loss-of-function in cancer. The Journal of Biological Chemistry. 100445. PMID 33617877 DOI: 10.1016/j.jbc.2021.100445 |
0.754 |
|
| 2020 |
Van AN, Kunkel MT, Baffi TR, Antal CE, Newton AC. Protein Kinase C Fusions Reveal Another Mechanism for Loss of Protein Kinase C Function in Cancer The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05363 |
0.756 |
|
| 2019 |
Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. PMID 30996350 DOI: 10.1038/S41586-019-1130-6 |
0.339 |
|
| 2019 |
Liang G, Hah N, Shi Y, Truitt ML, Antal CE, Atkins AR, Fraser C, Banayo E, Bashi S, Dai Y, Sherman M, Liddle C, Yu RT, Hunter T, Han H, et al. Abstract A29: Bicompartmental regulation of disease-related gene networks by histone deacetylase inhibition curbs pancreatic cancer progression Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A29 |
0.33 |
|
| 2019 |
Propper D, Han H, Hoff DV, Borazanci E, Reya T, Ghergurovich J, Pshenichnaya I, Antal C, Condjella R, Sharma S, O'Dwyer P, Littlewood T, Patel H, Saluja A, Velagapudi M, et al. Abstract CT165: Phase II open label trial of minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct165 |
0.316 |
|
| 2016 |
Newton AC, Antal CE, Steinberg SF. Protein kinase C mechanisms that contribute to cardiac remodelling. Clinical Science (London, England : 1979). 130: 1499-510. PMID 27433023 DOI: 10.1042/Cs20160036 |
0.688 |
|
| 2016 |
Alfonso SI, Callender JA, Hooli B, Antal CE, Mullin K, Sherman MA, Lesné SE, Leitges M, Newton AC, Tanzi RE, Malinow R. Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease. Science Signaling. 9: ra47. PMID 27165780 DOI: 10.1126/Scisignal.Aaf6209 |
0.562 |
|
| 2015 |
Antal CE, Callender JA, Kornev AP, Taylor SS, Newton AC. Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII. Cell Reports. 12: 1252-60. PMID 26279568 DOI: 10.1016/J.Celrep.2015.07.039 |
0.704 |
|
| 2015 |
Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB, Hunter T, Brognard J, Newton AC. Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor. Cell. 160: 489-502. PMID 25619690 DOI: 10.1016/J.Cell.2015.01.001 |
0.729 |
|
| 2015 |
Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller C, Furnari F, Hunter T, Brognard J, Newton AC. Abstract 125: Protein kinase C loss-of-function mutations in cancer reveal role as tumor suppressor Cancer Research. 75: 125-125. DOI: 10.1158/1538-7445.Am2015-125 |
0.78 |
|
| 2014 |
Antal CE, Newton AC. Tuning the signalling output of protein kinase C. Biochemical Society Transactions. 42: 1477-83. PMID 25399557 DOI: 10.1042/Bst20140172 |
0.66 |
|
| 2014 |
Antal CE, Violin JD, Kunkel MT, Skovsø S, Newton AC. Intramolecular conformational changes optimize protein kinase C signaling. Chemistry & Biology. 21: 459-69. PMID 24631122 DOI: 10.1016/J.Chembiol.2014.02.008 |
0.735 |
|
| 2014 |
Antal CE, Kang E, Stephenson NL, Trotter EW, Hunter T, Brognard J, Newton A. Abstract 5270: Prevalence of inactivating protein kinase C mutations in human cancers Cancer Research. 74: 5270-5270. DOI: 10.1158/1538-7445.Am2014-5270 |
0.784 |
|
| 2013 |
Antal CE, Newton AC. Spatiotemporal dynamics of phosphorylation in lipid second messenger signaling. Molecular & Cellular Proteomics : McP. 12: 3498-508. PMID 23788531 DOI: 10.1074/Mcp.R113.029819 |
0.671 |
|
| 2013 |
Scott AM, Antal CE, Newton AC. Electrostatic and hydrophobic interactions differentially tune membrane binding kinetics of the C2 domain of protein kinase Cα. The Journal of Biological Chemistry. 288: 16905-15. PMID 23589289 DOI: 10.1074/Jbc.M113.467456 |
0.732 |
|
| 2012 |
de Lichtervelde L, Antal CE, Boitano AE, Wang Y, Krastel P, Petersen F, Newton AC, Cooke MP, Schultz PG. Euphohelioscopin A is a PKC activator capable of inducing macrophage differentiation. Chemistry & Biology. 19: 994-1000. PMID 22921066 DOI: 10.1016/J.Chembiol.2012.06.010 |
0.57 |
|
| 2011 |
Gould CM, Antal CE, Reyes G, Kunkel MT, Adams RA, Ziyar A, Riveros T, Newton AC. Active site inhibitors protect protein kinase C from dephosphorylation and stabilize its mature form Journal of Biological Chemistry. 286: 28922-28930. PMID 21715334 DOI: 10.1074/Jbc.M111.272526 |
0.772 |
|
| Show low-probability matches. |